SCHEMBL4958840

SCHEMBL4958840

Fc1cccc(CNC2CN3CCC2CC3)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.68
KMT2A Q03164 1/20 0.68
GAA P10253 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
KDM1A O60341 2/20 0.52
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
CARM1 Q86X55 2/20 0.49
PRMT6 Q96LA8 2/20 0.49
SIGMAR1 Q99720 1/20 0.46
SLC6A2 P23975 1/20 0.45
HRH2 P25021 1/20 0.45
DRD3 P35462 1/20 0.45
SLC6A3 Q01959 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
CDK9 P50750 2/20 0.43
CHRNA7 P36544 1/20 0.43
HTR3A P46098 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958523 0.83 GAA (0.68) MEN1KMT2AGAASMN1; SMN2CARM1
SCHEMBL3364254 0.83 GAA (0.57) MEN1KMT2AGAASMN1; SMN2KDM1A
SCHEMBL3932594 0.82 GAA (0.70) MEN1KMT2AGAASMN1; SMN2KDM1A
Hydrochloric Acid SCHEMBL30366367 0.81 MEN1 (1.00) MEN1KMT2AGAASMN1; SMN2KDM1A
Hydrochloric Acid SCHEMBL14119342 0.81 MEN1 (1.00) MEN1KMT2AGAASMN1; SMN2KDM1A
SCHEMBL15667979 0.75 SLC6A4 (0.52) MEN1KMT2ASMN1; SMN2SLC6A3CHRM2
SCHEMBL4962589 0.74 GAA (0.68) MEN1KMT2AGAASMN1; SMN2KDM1A
SCHEMBL8252682 0.74 GAA (0.68) MEN1KMT2AGAASMN1; SMN2KDM1A
SCHEMBL2732150 0.74 CARM1 (0.63) MEN1KMT2AKDM1AMAOAMAOB
Hydrochloric Acid SCHEMBL4879048 0.72 CARM1 (0.62) MEN1KMT2AKDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558610-B1 SUBSTITUTED AMINOQUINUCLIDINE COMPOUNDS AND THEIR USE AS DELTA-OPIOID RECEPTOR LIGANDS JANSSEN PHARMACEUTICA NV (BE) 2008-02-27 EP disclosed
US-7179818-B2 Substituted aminoquinuclidine compounds ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2007-02-20 US disclosed
US-20040110789-A1 Substituted aminoquinuclidine compounds BOYD ROBERT E (US) 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110789-A1 Substituted aminoquinuclidine compounds OPRD1, OPRK1, OPRM1 MEN1 4876/4885KMT2A 1801/4885GAA 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.